Skip to content
Prostate Cancer Research Center

Faculty of Medicine and Health Technology

Epidemiology

2020

Search PubMed

2019

Search PubMed

2018

  1. van der Kwast, TH, Helleman, J, Nieboer, D, Bruinsma, SM, Roobol, MJ, Movember Foundation’s Global Action Plan Prostate Cancer Active Surveillance (GAP3) Consortium et al.. Consistent Biopsy Quality and Gleason Grading Within the Global Active Surveillance Global Action Plan 3 Initiative: A Prerequisite for Future Studies. Eur Urol Oncol. 2019;2 (3):333-336. doi: 10.1016/j.euo.2018.08.017. PubMed PMID:31200849 .
  2. Siltari, A, Murtola, TJ, Talala, K, Taari, K, Tammela, TLJ, Auvinen, A et al.. Antihypertensive drugs and prostate cancer risk in a Finnish population-based cohort. Scand J Urol. 2018;52 (5-6):321-327. doi: 10.1080/21681805.2018.1559882. PubMed PMID:30698056 .
  3. Deltour, I, Schlehofer, B, Massardier-Pilonchéry, A, Schlaefer, K, Armstrong, B, Giles, GG et al.. Exposure to loud noise and risk of vestibular schwannoma: results from the INTERPHONE international case‒control study. Scand J Work Environ Health. 2019;45 (2):183-193. doi: 10.5271/sjweh.3781. PubMed PMID:30614502 .
  4. Olsson, A, Bouaoun, L, Auvinen, A, Feychting, M, Johansen, C, Mathiesen, T et al.. Survival of glioma patients in relation to mobile phone use in Denmark, Finland and Sweden. J Neurooncol. 2019;141 (1):139-149. doi: 10.1007/s11060-018-03019-5. PubMed PMID:30421160 .
  5. Åkerla, J, Pesonen, JS, Pöyhönen, A, Häkkinen, J, Koskimäki, J, Huhtala, H et al.. Impact of lower urinary tract symptoms on mortality: a 21-year follow-up among middle-aged and elderly Finnish men. Prostate Cancer Prostatic Dis. 2019;22 (2):317-323. doi: 10.1038/s41391-018-0108-z. PubMed PMID:30410016 .
  6. Matejcic, M, Saunders, EJ, Dadaev, T, Brook, MN, Wang, K, Sheng, X et al.. Germline variation at 8q24 and prostate cancer risk in men of European ancestry. Nat Commun. 2018;9 (1):4616. doi: 10.1038/s41467-018-06863-1. PubMed PMID:30397198 PubMed Central PMC6218483.
  7. Van Hemelrijck, M, Ji, X, Helleman, J, Roobol, MJ, van der Linden, W, Nieboer, D et al.. Reasons for Discontinuing Active Surveillance: Assessment of 21 Centres in 12 Countries in the Movember GAP3 Consortium. Eur Urol. 2019;75 (3):523-531. doi: 10.1016/j.eururo.2018.10.025. PubMed PMID:30385049 PubMed Central PMC8542419.
  8. Pöyhönen, A, Åkerla, J, Häkkinen, JT, Koskimäki, J, Tammela, TLJ, Auvinen, A et al.. Severity and bother of lower urinary tract symptoms among men aged 30-80 years: Tampere Ageing Male Urological Study (TAMUS). Scand J Urol. 2018;52 (4):296-301. doi: 10.1080/21681805.2018.1505944. PubMed PMID:30382800 .
  9. Pakarainen, T, Nevalainen, J, Talala, K, Taari, K, Raitanen, J, Kujala, P et al.. The Number of Screening Cycles Needed to Reduce Prostate Cancer Mortality in the Finnish Section of the European Randomized Study of Prostate Cancer (ERSPC). Clin Cancer Res. 2019;25 (2):839-843. doi: 10.1158/1078-0432.CCR-18-1807. PubMed PMID:30322875 .
  10. Niskanen, L, Partonen, T, Auvinen, A, Haukka, J. Excess mortality in Finnish diabetic subjects due to alcohol, accidents and suicide: a nationwide study. Eur J Endocrinol. 2018;179 (5):299-306. doi: 10.1530/EJE-18-0351. PubMed PMID:30320503 .
  11. Togawa, K, Ahn, HS, Auvinen, A, Bauer, AJ, Brito, JP, Davies, L et al.. Long-term strategies for thyroid health monitoring after nuclear accidents: recommendations from an Expert Group convened by IARC. Lancet Oncol. 2018;19 (10):1280-1283. doi: 10.1016/S1470-2045(18)30680-6. PubMed PMID:30303113 .
  12. Murtola, TJ, Kasurinen, TVJ, Talala, K, Taari, K, Tammela, TLJ, Auvinen, A et al.. Serum cholesterol and prostate cancer risk in the Finnish randomized study of screening for prostate cancer. Prostate Cancer Prostatic Dis. 2019;22 (1):66-76. doi: 10.1038/s41391-018-0087-0. PubMed PMID:30214034 .
  13. Sipeky, C, Gao, P, Zhang, Q, Wang, L, Ettala, O, Talala, KM et al.. Synergistic Interaction of and Predisposes to Aggressive Prostate Cancer. Clin Cancer Res. 2018;24 (24):6265-6276. doi: 10.1158/1078-0432.CCR-18-0444. PubMed PMID:30181389 PubMed Central PMC6719560.
  14. Gao, P, Xia, JH, Sipeky, C, Dong, XM, Zhang, Q, Yang, Y et al.. Biology and Clinical Implications of the 19q13 Aggressive Prostate Cancer Susceptibility Locus. Cell. 2018;174 (3):576-589.e18. doi: 10.1016/j.cell.2018.06.003. PubMed PMID:30033361 PubMed Central PMC6091222.
  15. Kaapu, KJ, Rantaniemi, L, Talala, K, Taari, K, Tammela, TLJ, Auvinen, A et al.. Cancer mortality does not differ by antiarrhythmic drug use: A population-based cohort of Finnish men. Sci Rep. 2018;8 (1):10308. doi: 10.1038/s41598-018-28541-4. PubMed PMID:29985440 PubMed Central PMC6037774.
  16. Hsu, CY, Yen, MF, Auvinen, A, Chiu, YH, Chen, HH. Bayesian negative-binomial-family-based multistate Markov model for the evaluation of periodic population-based cancer screening considering incomplete information and measurement errors. Stat Methods Med Res. 2018;27 (8):2519-2539. doi: 10.1177/0962280216682284. PubMed PMID:29984633 .
  17. Nikkilä, A, Raitanen, J, Lohi, O, Auvinen, A. Radiation exposure from computerized tomography and risk of childhood leukemia: Finnish register-based case-control study of childhood leukemia (FRECCLE). Haematologica. 2018;103 (11):1873-1880. doi: 10.3324/haematol.2018.187716. PubMed PMID:29976736 PubMed Central PMC6278981.
  18. Nikkilä, A, Kendall, G, Raitanen, J, Spycher, B, Lohi, O, Auvinen, A et al.. Effects of incomplete residential histories on studies of environmental exposure with application to childhood leukaemia and background radiation. Environ Res. 2018;166 :466-472. doi: 10.1016/j.envres.2018.06.035. PubMed PMID:29945121 .
  19. Dadaev, T, Saunders, EJ, Newcombe, PJ, Anokian, E, Leongamornlert, DA, Brook, MN et al.. Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants. Nat Commun. 2018;9 (1):2256. doi: 10.1038/s41467-018-04109-8. PubMed PMID:29892050 PubMed Central PMC5995836.
  20. Schumacher, FR, Al Olama, AA, Berndt, SI, Benlloch, S, Ahmed, M, Saunders, EJ et al.. Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci. Nat Genet. 2018;50 (7):928-936. doi: 10.1038/s41588-018-0142-8. PubMed PMID:29892016 PubMed Central PMC6568012.
  21. Ryödi, E, Metso, S, Huhtala, H, Välimäki, M, Auvinen, A, Jaatinen, P et al.. Cardiovascular Morbidity and Mortality After Treatment of Hyperthyroidism with Either Radioactive Iodine or Thyroidectomy. Thyroid. 2018;28 (9):1111-1120. doi: 10.1089/thy.2017.0461. PubMed PMID:29882483 .
  22. Barchuk, A, Bespalov, A, Huhtala, H, Chimed, T, Laricheva, I, Belyaev, A et al.. Breast and cervical cancer incidence and mortality trends in Russia 1980-2013. Cancer Epidemiol. 2018;55 :73-80. doi: 10.1016/j.canep.2018.05.008. PubMed PMID:29843073 .
  23. Petridou, ET, Georgakis, MK, Erdmann, F, Ma, X, Heck, JE, Auvinen, A et al.. Advanced parental age as risk factor for childhood acute lymphoblastic leukemia: results from studies of the Childhood Leukemia International Consortium. Eur J Epidemiol. 2018;33 (10):965-976. doi: 10.1007/s10654-018-0402-z. PubMed PMID:29761423 PubMed Central PMC6384148.
  24. Auvinen, A. Prostate cancer screening: what can we learn from randomised trials?. Transl Androl Urol. 2018;7 (1):12-17. doi: 10.21037/tau.2017.12.13. PubMed PMID:29594015 PubMed Central PMC5861281.
  25. Murtola, TJ, Vihervuori, VJ, Lahtela, J, Talala, K, Taari, K, Tammela, TL et al.. Fasting blood glucose, glycaemic control and prostate cancer risk in the Finnish Randomized Study of Screening for Prostate Cancer. Br J Cancer. 2018;118 (9):1248-1254. doi: 10.1038/s41416-018-0055-4. PubMed PMID:29563633 PubMed Central PMC5943324.
  26. Booth, N, Rissanen, P, Tammela, TLJ, Taari, K, Talala, K, Auvinen, A et al.. Costs of screening for prostate cancer: Evidence from the Finnish Randomised Study of Screening for Prostate Cancer after 20-year follow-up using register data. Eur J Cancer. 2018;93 :108-118. doi: 10.1016/j.ejca.2018.01.111. PubMed PMID:29501976 .
  27. Kukko, V, Kaipia, A, Talala, K, Taari, K, Tammela, TLJ, Auvinen, A et al.. Allopurinol and risk of benign prostatic hyperplasia in a Finnish population-based cohort. Prostate Cancer Prostatic Dis. 2018;21 (3):373-378. doi: 10.1038/s41391-017-0031-8. PubMed PMID:29273728 .
  28. Bruinsma, SM, Zhang, L, Roobol, MJ, Bangma, CH, Steyerberg, EW, Nieboer, D et al.. The Movember Foundation’s GAP3 cohort: a profile of the largest global prostate cancer active surveillance database to date. BJU Int. 2018;121 (5):737-744. doi: 10.1111/bju.14106. PubMed PMID:29247473 .
  29. Neupane, S, Steyerberg, E, Raitanen, J, Talala, K, Pylväläinen, J, Taari, K et al.. Prognostic factors of prostate cancer mortality in a Finnish randomized screening trial. Int J Urol. 2018;25 (3):270-276. doi: 10.1111/iju.13508. PubMed PMID:29224236 .
  30. de Koning, HJ, Gulati, R, Moss, SM, Hugosson, J, Pinsky, PF, Berg, CD et al.. The efficacy of prostate-specific antigen screening: Impact of key components in the ERSPC and PLCO trials. Cancer. 2018;124 (6):1197-1206. doi: 10.1002/cncr.31178. PubMed PMID:29211316 PubMed Central PMC5839977.
  31. Toledano, MB, Auvinen, A, Tettamanti, G, Cao, Y, Feychting, M, Ahlbom, A et al.. An international prospective cohort study of mobile phone users and health (COSMOS): Factors affecting validity of self-reported mobile phone use. Int J Hyg Environ Health. 2018;221 (1):1-8. doi: 10.1016/j.ijheh.2017.09.008. PubMed PMID:29056311 .
  32. Murtola, TJ, Vettenranta, AM, Talala, K, Taari, K, Stenman, UH, Tammela, TLJ et al.. Outcomes of Prostate-specific Antigen-based Prostate Cancer Screening Among Men Using Nonsteroidal Anti-inflammatory Drugs. Eur Urol Focus. 2018;4 (6):851-857. doi: 10.1016/j.euf.2017.03.005. PubMed PMID:28753870 .

Search PubMed

2017

Search PubMed

2016

Search PubMed

2015

  1. Nevalainen, O, Simola, M, Ansakorpi, H, Raitanen, J, Artama, M, Isojärvi, J et al.. Epilepsy, excess deaths and years of life lost from external causes. Eur J Epidemiol. 2016;31 (5):445-53. doi: 10.1007/s10654-015-0095-5. PubMed PMID:26520637 .
  2. Rahu, K, Rahu, M, Tekkel, M, Veidebaum, T, Hakulinen, T, Auvinen, A et al.. Chernobyl cleanup workers from Estonia: cohort description and related epidemiological research. J Radiol Prot. 2015;35 (4):R35-45. doi: 10.1088/0952-4746/35/4/R35. PubMed PMID:26512763 .
  3. Auvinen, A. [How do I write a scientific article–advice to a young researcher]. Duodecim. 2015;131 (16):1460-6. . PubMed PMID:26485939 .
  4. Friis, S, Kesminiene, A, Espina, C, Auvinen, A, Straif, K, Schüz, J et al.. European Code against Cancer 4th Edition: Medical exposures, including hormone therapy, and cancer. Cancer Epidemiol. 2015;39 Suppl 1 :S107-19. doi: 10.1016/j.canep.2015.08.003. PubMed PMID:26390952 .
  5. Davies, NM, Gaunt, TR, Lewis, SJ, Holly, J, Donovan, JL, Hamdy, FC et al.. The effects of height and BMI on prostate cancer incidence and mortality: a Mendelian randomization study in 20,848 cases and 20,214 controls from the PRACTICAL consortium. Cancer Causes Control. 2015;26 (11):1603-16. doi: 10.1007/s10552-015-0654-9. PubMed PMID:26387087 PubMed Central PMC4596899.
  6. Pashayan, N, Pharoah, PD, Schleutker, J, Talala, K, Tammela, TLj, Määttänen, L et al.. Reducing overdiagnosis by polygenic risk-stratified screening: findings from the Finnish section of the ERSPC. Br J Cancer. 2015;113 (7):1086-93. doi: 10.1038/bjc.2015.289. PubMed PMID:26291059 PubMed Central PMC4651137.
  7. Auvinen, A, Moss, SM, Tammela, TL, Taari, K, Roobol, MJ, Schröder, FH et al.. Absolute Effect of Prostate Cancer Screening: Balance of Benefits and Harms by Center within the European Randomized Study of Prostate Cancer Screening. Clin Cancer Res. 2016;22 (1):243-9. doi: 10.1158/1078-0432.CCR-15-0941. PubMed PMID:26289069 PubMed Central PMC4951205.
  8. Ryödi, E, Metso, S, Jaatinen, P, Huhtala, H, Saaristo, R, Välimäki, M et al.. Cancer Incidence and Mortality in Patients Treated Either With RAI or Thyroidectomy for Hyperthyroidism. J Clin Endocrinol Metab. 2015;100 (10):3710-7. doi: 10.1210/jc.2015-1874. PubMed PMID:26262435 .
  9. Eloranta, K, Auvinen, A. Population attitudes towards research use of health care registries: a population-based survey in Finland. BMC Med Ethics. 2015;16 :48. doi: 10.1186/s12910-015-0040-x. PubMed PMID:26183438 PubMed Central PMC4504396.
  10. Szulkin, R, Whitington, T, Eklund, M, Aly, M, Eeles, RA, Easton, D et al.. Prediction of individual genetic risk to prostate cancer using a polygenic score. Prostate. 2015;75 (13):1467-74. doi: 10.1002/pros.23037. PubMed PMID:26177737 PubMed Central PMC7745998.
  11. Schüz, J, Espina, C, Villain, P, Herrero, R, Leon, ME, Minozzi, S et al.. European Code against Cancer 4th Edition: 12 ways to reduce your cancer risk. Cancer Epidemiol. 2015;39 Suppl 1 :S1-10. doi: 10.1016/j.canep.2015.05.009. PubMed PMID:26164654 .
  12. McColl, N, Auvinen, A, Kesminiene, A, Espina, C, Erdmann, F, de Vries, E et al.. European Code against Cancer 4th Edition: Ionising and non-ionising radiation and cancer. Cancer Epidemiol. 2015;39 Suppl 1 :S93-100. doi: 10.1016/j.canep.2015.03.016. PubMed PMID:26126928 .
  13. Nevalainen, OP, Ansakorpi, H, Auvinen, A. Epilepsy-related clinical characteristics and mortality: a systematic review and meta-analysis. Neurology. 2015;84 (17):1823-4. . PubMed PMID:26106661 .
  14. Greinert, R, de Vries, E, Erdmann, F, Espina, C, Auvinen, A, Kesminiene, A et al.. European Code against Cancer 4th Edition: Ultraviolet radiation and cancer. Cancer Epidemiol. 2015;39 Suppl 1 :S75-83. doi: 10.1016/j.canep.2014.12.014. PubMed PMID:26096748 .
  15. Veitonmäki, T, Murtola, TJ, Määttänen, L, Taari, K, Stenman, UH, Tammela, TL et al.. Use of non-steroidal anti-inflammatory drugs and prostate cancer survival in the Finnish prostate cancer screening trial. Prostate. 2015;75 (13):1394-402. doi: 10.1002/pros.23020. PubMed PMID:26073992 .
  16. Kreuzer, M, Auvinen, A, Cardis, E, Hall, J, Jourdain, JR, Laurier, D et al.. Low-dose ionising radiation and cardiovascular diseases–Strategies for molecular epidemiological studies in Europe. Mutat Res Rev Mutat Res. 2015;764 :90-100. doi: 10.1016/j.mrrev.2015.03.002. PubMed PMID:26041268 .
  17. Amin Al Olama, A, Dadaev, T, Hazelett, DJ, Li, Q, Leongamornlert, D, Saunders, EJ et al.. Multiple novel prostate cancer susceptibility signals identified by fine-mapping of known risk loci among Europeans. Hum Mol Genet. 2015;24 (19):5589-602. doi: 10.1093/hmg/ddv203. PubMed PMID:26025378 PubMed Central PMC4572072.
  18. Shrestha, M, Raitanen, J, Salminen, T, Lahkola, A, Auvinen, A. Pituitary tumor risk in relation to mobile phone use: A case-control study. Acta Oncol. 2015;54 (8):1159-65. doi: 10.3109/0284186X.2015.1045624. PubMed PMID:25982941 .
  19. Schröder, F, Hugosson, J, Carlsson, S, Moss, S, Roobol, M, Auvinen, A et al.. Prostate cancer screening in Europe – Authors’ reply. Lancet. 2015;385 (9977):1507-8. doi: 10.1016/S0140-6736(15)60749-8. PubMed PMID:25933276 .
  20. Auvinen, A, Kivelä, T, Heinävaara, S, Mrena, S. Eye Lens Opacities Among Physicians Occupationally Exposed to Ionizing Radiation. Ann Occup Hyg. 2015;59 (7):945-8. doi: 10.1093/annhyg/mev022. PubMed PMID:25868644 .
  21. Amin Al Olama, A, Benlloch, S, Antoniou, AC, Giles, GG, Severi, G, Neal, DE et al.. Risk Analysis of Prostate Cancer in PRACTICAL, a Multinational Consortium, Using 25 Known Prostate Cancer Susceptibility Loci. Cancer Epidemiol Biomarkers Prev. 2015;24 (7):1121-9. doi: 10.1158/1055-9965.EPI-14-0317. PubMed PMID:25837820 PubMed Central PMC4491026.
  22. Murtola, TJ, Wahlfors, T, Haring, A, Taari, K, Stenman, UH, Tammela, TL et al.. Polymorphisms of Genes Involved in Glucose and Energy Metabolic Pathways and Prostate Cancer: Interplay with Metformin. Eur Urol. 2015;68 (6):1089-97. doi: 10.1016/j.eururo.2015.03.026. PubMed PMID:25819720 .
  23. Buzzoni, C, Auvinen, A, Roobol, MJ, Carlsson, S, Moss, SM, Puliti, D et al.. Metastatic Prostate Cancer Incidence and Prostate-specific Antigen Testing: New Insights from the European Randomized Study of Screening for Prostate Cancer. Eur Urol. 2015;68 (5):885-90. doi: 10.1016/j.eururo.2015.02.042. PubMed PMID:25791513 PubMed Central PMC4982869.
  24. Stegeman, S, Amankwah, E, Klein, K, O’Mara, TA, Kim, D, Lin, HY et al.. A Large-Scale Analysis of Genetic Variants within Putative miRNA Binding Sites in Prostate Cancer. Cancer Discov. 2015;5 (4):368-79. doi: 10.1158/2159-8290.CD-14-1057. PubMed PMID:25691096 PubMed Central PMC4390388.
  25. Yen, AM, Auvinen, A, Schleutker, J, Wu, YY, Fann, JC, Tammela, T et al.. Prostate cancer screening using risk stratification based on a multi-state model of genetic variants. Prostate. 2015;75 (8):825-35. doi: 10.1002/pros.22964. PubMed PMID:25683204 .
  26. Kaapu, KJ, Ahti, J, Tammela, TL, Auvinen, A, Murtola, TJ. Sotalol, but not digoxin is associated with decreased prostate cancer risk: A population-based case-control study. Int J Cancer. 2015;137 (5):1187-95. doi: 10.1002/ijc.29470. PubMed PMID:25656312 .
  27. Kilpeläinen, TP, Tammela, TL, Malila, N, Hakama, M, Santti, H, Määttänen, L et al.. The Finnish prostate cancer screening trial: analyses on the screening failures. Int J Cancer. 2015;136 (10):2437-43. doi: 10.1002/ijc.29300. PubMed PMID:25359457 .
  28. Saarimäki, L, Tammela, TL, Määttänen, L, Taari, K, Kujala, PM, Raitanen, J et al.. Family history in the Finnish Prostate Cancer Screening Trial. Int J Cancer. 2015;136 (9):2172-7. doi: 10.1002/ijc.29243. PubMed PMID:25274038 .

Search PubMed